Form D · Biotechnology
CERAPEDICS INC
Westminster, CO · CIK 0001393439
Offering snapshot reported Mar 7, 2022 · SEC filing
- Reported sold
- $25M Offering amount: $25M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 18, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 7, 2022 | Initial | $24,999,997 | No comparison | 6 | SEC filing |
| Jul 6, 2018 | Initial | $21,999,998 | No comparison | 2 | SEC filing |
| Sep 26, 2016 | Initial | $11,000,000 | No comparison | 8 | SEC filing |
| Feb 23, 2015 | Initial | $4,000,000 | No comparison | 5 | SEC filing |
| Nov 27, 2012 | Amendment | $0 | -$12,090,328vs Jul 20, 2012 | 5 | SEC filing |
| Jul 20, 2012 | Initial | $12,090,328 | No comparison | 4 | SEC filing |
| Feb 16, 2012 | Initial | $3,000,000 | No comparison | 3 | SEC filing |
| Mar 30, 2009 | Initial | $15,000,000 | No comparison | Not reported | SEC filing |
| Mar 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-436158
Source: Form D, filed Mar 7, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ken Abramowitz | Director |
| Jerome Connor | Executive |
| Greg Garfield | Director |
| Leonard Habas | Director |
| Andrew Handwerker | Executive |
| Glen Kashuba | Director, Executive |
| Nael Kassar | Director |
| Chau Khuong | Director |
| Antony Koblish | Director |
| Doug Kohrs | Director |
| Noah Kroloff | Director |
| Jeffrey G. Marx | Executive |
| Jeff Marx | Executive |
| Paul J. Mraz | Director, Executive |
| Britt Pearson | Executive |
| Tyrell Rivers | Director |
| Chen Schor | Director |
| Valeska Schroeder | Director |
| Jonathan Silverstein | Director |
| John Tattory | Executive |
| Andrew J. Tofe | Director |
| Drew Trivisonno | Executive |
| Samuel S. Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11025 Dover Street Suite 1600
Westminster, CO, 80021
Westminster, CO, 80021